期刊
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
卷 39, 期 6, 页码 406-409出版社
OXFORD UNIV PRESS
DOI: 10.1093/jjco/hyp035
关键词
colorectal cancer; liver metastases; randomized controlled trial; mFOLFOX6
类别
资金
- Ministry of Health, Labour and Welfare, Japan
A randomized controlled trial is being conducted in Japan to compare hepatectomy alone with hepatectomy followed by adjuvant chemotherapy as treatment in patients with curatively resected liver metastases from colorectal cancer to improve survival with intensive chemotherapy. Between 42 and 70 days after liver resection, patients are randomly assigned to either hepatectomy alone or hepatectomy followed by 12 cycles of modified FOLFOX6 (mFOLFOX6) regimen. A total of 300 patients (including 78 patients in Phase II) will be accrued from 38 institutions within 3 years. The primary endpoint is treatment compliance at nine courses of mFOLFOX6 regimen in Phase II and disease-free survival in Phase III. The secondary endpoints are overall survival, incidence of adverse events and patterns of recurrence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据